Haven't used BioMedical Enterprises yet?
Ask Trustburn

Ask Trustburn about BioMedical Enterprises

Based on 8 reviews on Trustburn

Based on reviews on this page. Verify anything important with the company directly.

Robyn Cooper
Reviews 1

We have been using BioMedical Enterprises products for several years now, and we are extremely happy with the results. The quality of their products is outstanding, and the customer service is excellent. Their website is easy to navigate and the ordering process is simple. Highly recommend!

Cynthia Shelby
Reviews 1

😊 BioMedical Enterprises has been a game-changer for us. Their products are of great quality and the customer service is amazing. The website is very user-friendly and the ordering process is seamless. I can't recommend them enough! 😊

Questions & Answers

No questions yet — be the first to ask.

News & Press

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying widget on your website — its a simple way to convert your visitors into customers.

Embed code

<script src="https://trustburn.com/widgets/index.js"></script>
<div class="trustburn-widget" data-trustburn-protocol="https:" data-trustburn-domain="trustburn.com" data-trustburn-widget="score" data-company-path="bme-tx-com" data-lang="en"></div>
More widgets

About BioMedical Enterprises

Biomedical Enterprises Inc. (BME) was founded to research, develop and commercialize medical products. BME's first product, an innovative dialysis needle (the BME needle), reduces patient complications resulting from hemodialysis, thereby increasing revenue for dialysis clinics and reducing cost for medical insurers. The BME needle provides a solution to the number one problem plaguing dialysis clinics, dialysis patients and insurers - clotting and occlusion of the vascular access. In addition, the BME needle appears to reduce inflammation and oxidative stress which also decrease the occurrence of medical complications. The company is raising funds to commercialize the needle and in the process of obtaining government approval for commercialization. The company has obtained about $1.0 million in grants from the U.S. National Institute of Health for R&D.

Website
bme-tx.com
Address
14785 Omicron Dr